000 01550 a2200373 4500
005 20250517052513.0
264 0 _c20160819
008 201608s 0 0 eng d
022 _a1557-3265
024 7 _a10.1158/1078-0432.CCR-15-0479
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKarnitz, Larry M
245 0 0 _aMolecular Pathways: Targeting ATR in Cancer Therapy.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cNov 2015
300 _a4780-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aAtaxia Telangiectasia Mutated Proteins
_xantagonists & inhibitors
650 0 4 _aCheckpoint Kinase 1
650 0 4 _aClinical Trials as Topic
650 0 4 _aDNA Damage
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aProtein Kinases
_xmetabolism
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTranslational Research, Biomedical
650 0 4 _aTreatment Outcome
700 1 _aZou, Lee
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 21
_gno. 21
_gp. 4780-5
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-15-0479
_zAvailable from publisher's website
999 _c25254473
_d25254473